215 related articles for article (PubMed ID: 8419005)
21. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM.
Beanlands RS; Muzik O; Hutchins GD; Wolfe ER; Schwaiger M
J Nucl Cardiol; 1994; 1(3):225-35. PubMed ID: 9420705
[TBL] [Abstract][Full Text] [Related]
22. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
[TBL] [Abstract][Full Text] [Related]
23. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography.
Herrero P; Markham J; Shelton ME; Bergmann SR
Circ Res; 1992 Mar; 70(3):496-507. PubMed ID: 1537087
[TBL] [Abstract][Full Text] [Related]
24. Copper-62-pyruvaldehyde bis(N-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans.
Wallhaus TR; Lacy J; Stewart R; Bianco J; Green MA; Nayak N; Stone CK
J Nucl Cardiol; 2001; 8(1):67-74. PubMed ID: 11182711
[TBL] [Abstract][Full Text] [Related]
25. Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.
Zweit J; Goodall R; Cox M; Babich JW; Potter GA; Sharma HL; Ott RJ
Eur J Nucl Med; 1992; 19(6):418-25. PubMed ID: 1618233
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
27. Assessment of myocardial perfusion by positron emission tomography.
Schwaiger M; Muzik O
Am J Cardiol; 1991 May; 67(14):35D-43D. PubMed ID: 2035433
[TBL] [Abstract][Full Text] [Related]
28. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
29. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ
Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
[TBL] [Abstract][Full Text] [Related]
32. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
33. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with 201T1 and 14C-iodoantipyrine.
Wada K; Fujibayashi Y; Taniuchi H; Tajima N; Tamaki N; Konishi J; Yokoyama A
Nucl Med Biol; 1994 May; 21(4):613-7. PubMed ID: 9234318
[TBL] [Abstract][Full Text] [Related]
34. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model.
Herrero P; Markham J; Shelton ME; Weinheimer CJ; Bergmann SR
Circulation; 1990 Oct; 82(4):1377-86. PubMed ID: 2401071
[TBL] [Abstract][Full Text] [Related]
36. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.
Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Nakano A; Lee JD; Itoh H
Ann Nucl Med; 2001 Jun; 15(3):293-6. PubMed ID: 11545205
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Itoh H
Ann Nucl Med; 2000 Oct; 14(5):323-8. PubMed ID: 11108159
[TBL] [Abstract][Full Text] [Related]
38. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.
Taniuchi H; Fujibayashi Y; Yonekura Y; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1130-4. PubMed ID: 9225805
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
40. Investigation of copper-PTSM as a PET tracer for tumor blood flow.
Mathias CJ; Welch MJ; Perry DJ; McGuire AH; Zhu X; Connett JM; Green MA
Int J Rad Appl Instrum B; 1991; 18(7):807-11. PubMed ID: 1787092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
